perform
retrospect
cohort
studi
preterm
infant
born
kk
women
children
hospit
kkh
singapor
period
liveborn
verylowbirthweight
vlbw
infant
born
week
complet
gestat
age
admit
hospit
neonat
unit
includ
infant
major
congenit
anomali
stillbirth
laborroom
death
exclud
data
includ
infant
year
age
kkh
referr
hospit
largest
tertiarylevel
perinat
center
singapor
nicu
bed
special
care
nurseri
bed
kkh
provid
care
pregnant
women
preterm
infant
annual
specialist
women
children
public
hospit
singapor
neonat
depart
care
twothird
infant
born
g
singapor
around
infant
week
gestat
week
admit
kkh
nicu
annual
isol
cohort
practic
rviinfect
patient
potenti
contact
initi
contact
droplet
precaut
appropri
children
year
age
bar
unit
staff
visitor
advis
enter
unit
unwel
standard
clinic
practic
patient
admit
kkh
histori
respiratori
symptom
eg
cough
coryza
breath
difficulti
nasopharyng
swab
test
respiratori
virus
initi
via
direct
immunofluoresc
subsequ
sampl
may
also
sent
multiplex
polymeras
chain
reaction
pcr
test
strong
suspicion
rvi
despit
neg
immunofluoresc
test
kkh
vlbw
clinic
databas
record
perinat
neonat
matern
inform
use
standard
data
collect
form
liveborn
infant
g
hospit
data
crosscheck
valid
audit
offic
submiss
electron
databas
extract
line
list
posit
rvi
hospit
microbiolog
laboratori
databas
januari
decemb
data
linkag
perform
kkh
vlbw
databas
laboratori
extract
use
uniqu
nation
identif
number
number
alloc
everi
babi
born
singapor
gestat
age
defin
best
estim
complet
week
base
obstetr
histori
clinic
examin
prenat
ultrasound
bronchopulmonari
dysplasia
bpd
defin
oxygen
requir
respiratori
support
chronic
pulmonari
disord
week
postmenstru
age
infant
small
gestat
age
sga
birth
weight
percentil
accord
fenton
growth
chart
histolog
chorioamnion
presenc
inflammatori
cell
chorioamniot
membran
umbil
cord
andor
placent
disc
postnat
steroid
usag
provis
inhal
oral
andor
parenter
steroid
treatment
chronic
lung
diseas
viral
infect
detect
use
standard
laboratori
fluoresc
antibodi
dfa
andor
multiplex
realtim
pcr
assay
virus
detect
dfa
doubl
duet
dfa
respiratori
viru
screen
id
kit
diagnost
hybrid
athen
ohio
includ
influenza
influenza
b
rsv
adenoviru
hmpv
per
manufactur
document
posit
percentag
agreement
viru
detect
test
predic
test
confid
interv
ci
neg
agreement
ci
onward
commerci
multiplex
pcr
kit
seeplex
ace
detect
kit
seegen
seoul
korea
introduc
depart
follow
addit
virus
detect
coronaviru
coronaviru
bocaviru
rhinoviru
enteroviru
supplementari
tabl
posit
result
organ
repeat
multipl
test
admiss
count
episod
separ
rvi
episod
count
subsequ
admiss
differ
viru
least
day
previou
episod
compar
variabl
interest
infant
without
rvi
use
test
proport
mannwhitney
u
test
appropri
analysi
perform
whole
studi
popul
also
subgroup
differ
respiratori
virus
comparison
also
made
clinic
characterist
rvi
distribut
predischarg
postdeliveri
prior
initi
discharg
postdischarg
period
gestat
age
agespecif
rvi
incid
rate
calcul
laboratoryconfirm
rvi
episod
per
infantyear
gestat
age
categori
week
week
week
chronolog
age
categori
month
month
month
year
year
infantyear
count
time
birth
year
age
rvi
death
durat
observ
adjust
appropri
infant
born
includ
time
end
studi
period
decemb
calcul
rsv
incid
infant
receiv
palivizumab
n
exclud
analysi
multivari
logist
regress
analysi
perform
follow
predetermin
clinic
relev
variabl
gender
sga
statu
gestat
age
week
vagin
deliveri
apgar
score
receipt
antenat
steroid
receipt
surfact
receipt
postnat
steroid
presenc
placent
histolog
chorioamnion
presenc
bpd
odd
ratio
or
adjust
odd
ratio
aor
express
ci
level
signific
use
comparison
use
studi
statist
analys
perform
use
ibm
spss
statist
version
ibm
corpor
armonk
new
york
ethic
approv
obtain
singhealth
centralis
institut
review
board
total
vlbw
infant
week
gestat
born
kkh
exclus
stillbirthslabor
room
death
liveborn
infant
admit
nicu
includ
studi
infant
diagnos
rvi
within
first
year
life
tabl
posit
pre
postdischarg
respect
fortyseven
infant
episod
rvi
result
total
rvi
event
studi
period
rsv
piv
influenza
hmpv
common
viral
caus
respiratori
infect
cohort
account
respiratori
virus
detect
tabl
infant
develop
rvi
predischarg
signific
proport
due
piv
follow
rsv
howev
postdischarg
main
caus
pathogen
communityacquir
laboratoryconfirm
rvi
rsv
approxim
cohort
readmit
least
episod
rsv
rate
influenza
infect
low
similar
pre
postdischarg
viral
coinfect
detect
studi
overal
incid
rvi
estim
per
infantyear
cohort
infant
born
week
gestat
highest
incid
rvi
per
infantyear
incid
week
week
per
infantyear
respect
predischarg
incid
rvi
similar
group
week
gestat
figur
incid
rsv
highest
week
per
infantyear
piv
incid
highest
week
per
infantyear
postdischarg
infant
week
highest
incid
rvi
rsv
piv
median
chronolog
age
infect
rvi
month
interquartil
rang
overal
incid
rvi
highest
month
age
period
per
infantyear
predischarg
rsv
infect
occur
infant
month
similarli
piv
infect
occur
infant
month
postdischarg
infant
highest
risk
rvi
hospit
month
old
per
infantyear
figur
peak
incid
rsv
hospit
month
old
per
infantyear
follow
close
month
old
per
infantyear
month
year
per
infantyear
note
none
receiv
palivizumab
discharg
posit
rsv
studi
period
signific
differ
compar
baselin
characterist
infant
rvi
initi
discharg
n
infect
postdischarg
n
infant
infect
predischarg
higher
median
durat
oxygen
therapi
day
vs
day
p
higher
median
durat
assist
ventil
day
vs
day
p
base
univari
analysi
clinic
risk
factor
associ
rvi
studi
includ
gestat
age
week
lower
birth
weight
male
sex
presenc
histolog
chorioamnion
vagin
deliveri
surfact
usag
postnat
steroid
treatment
longer
durat
oxygen
therapi
longer
durat
assist
ventil
histori
bpd
tabl
multivari
adjust
risk
factor
remain
signific
gestat
age
week
aor
ci
postnat
steroid
treatment
aor
ci
diagnosi
bpd
aor
ci
tabl
singlecent
cohort
studi
preterm
infant
week
gestat
acquir
least
laboratoryconfirm
rvi
within
first
year
life
repres
overal
incid
per
infantyear
approxim
acquir
rvi
predischarg
piv
rsv
main
caus
pathogen
inhospit
major
rvi
occur
postdischarg
attribut
rsv
preterm
infant
commun
highest
risk
rsv
infect
requir
hospit
month
old
incid
remain
high
year
age
risk
factor
significantli
associ
rvi
extrem
low
gestat
age
week
treatment
postnat
steroid
diagnosi
bpd
rvi
proport
cohort
similar
report
elsewher
howev
studi
includ
respiratori
virus
beyond
rsv
major
report
beyond
first
month
life
proport
rvi
inpati
predischarg
set
much
lower
incid
report
nicu
studi
higher
incid
previou
studi
like
due
differ
studi
design
studi
perform
period
surveil
test
rvi
studi
includ
symptomat
infant
rvi
admiss
approach
may
miss
infant
mild
symptom
asymptomat
furthermor
differ
test
methodolog
primari
usag
multiplex
pcr
may
account
differ
incid
lower
rvi
rate
could
also
possibl
attribut
strict
enforc
infect
control
polici
depart
similar
publish
infect
prevent
guidelin
even
guidelin
specif
neonat
set
lack
effect
intervent
systemat
studi
differ
test
strategi
laboratori
methodolog
also
like
account
lack
viral
codetect
studi
report
pediatr
studi
surveil
studi
report
viru
codetect
primarili
util
sensit
pcr
techniqu
compar
respiratori
viru
detect
via
pcr
dearth
data
epidemiolog
burden
rvi
tropic
unabl
identifi
longterm
studi
preterm
infant
week
gestat
previou
studi
conduct
temper
region
season
transmiss
virus
rsv
influenza
winter
month
difficult
extrapol
data
studi
tropic
differ
climat
factor
yearround
circul
rsv
like
affect
transmiss
pattern
exposur
risk
among
preterm
infant
tropic
region
specif
studi
rsv
temper
countri
report
broad
rang
rsv
hospit
rate
preterm
infant
found
preterm
infant
hospit
rsv
tropic
set
virus
piv
influenza
hmpv
import
contributor
infect
rehospit
preterm
infant
account
diagnos
rvi
concur
previou
observ
piv
hmpv
import
pathogen
popul
specif
apart
rsv
note
piv
rhinoviru
common
predischarg
period
account
rvi
limit
inform
incid
morbid
piv
infect
preterm
infant
report
come
outbreak
piv
infect
result
lower
respiratori
tract
infect
signific
morbid
howev
comparison
rsv
symptom
piv
reportedli
less
sever
less
hypoxia
less
need
intens
care
data
burden
agespecif
distribut
rsv
critic
inform
rsv
immun
public
health
polici
priorit
research
high
rsv
infect
incid
age
group
highlight
substanti
burden
risk
rsv
preterm
infant
week
tropic
advanc
rsv
vaccin
enter
phase
trial
start
recruit
assess
effect
matern
immun
protect
infant
unfortun
matern
immun
strategi
unlik
benefit
preterm
babi
transplacent
transfer
antibodi
mainli
occur
around
week
gestat
urgent
need
develop
rsv
vaccin
immunogen
safe
preterm
infant
administ
soon
deliveri
august
onward
palivizumab
avail
elig
infant
set
accord
establish
guidelin
howev
due
high
cost
uptak
elig
infant
studi
period
although
none
receiv
palivizumab
develop
rsv
unabl
make
conclus
regard
effect
studi
design
address
question
recent
progress
monoclon
antibodi
extend
halflif
month
could
significantli
improv
current
rsv
immunoprophylaxi
strategi
importantli
could
help
meet
need
yearround
protect
preterm
infant
tropic
protect
beyond
month
age
may
use
view
find
high
rsv
incid
month
year
identifi
infant
born
week
gestat
treat
postnat
steroid
andor
bpd
increas
risk
develop
rvi
within
first
year
life
associ
postnat
steroid
treatment
rvi
previous
describ
like
indic
sever
underli
lung
diseas
relat
prematur
analysi
includ
perinat
predischarg
factor
unabl
analyz
contribut
social
environment
factor
may
lead
rvi
postdischarg
unlik
studi
find
sex
chorioamnion
sga
statu
signific
risk
rvi
cohort
find
higher
proport
infant
rvi
placent
chorioamnion
signific
regress
analysi
contrast
recent
find
increas
risk
lower
respiratori
tract
infect
infant
histolog
chorioamnion
incid
rvi
studi
like
underestim
true
burden
rvi
preterm
popul
includ
admit
symptomat
infant
test
posit
respiratori
viru
studi
investig
burden
rvi
among
nonhospit
infant
commun
rvi
test
base
symptomatolog
potenti
exposur
like
miss
asymptomat
mildli
symptomat
infant
preterm
infant
rvi
may
present
apnea
classic
symptom
fever
cough
runni
nose
may
present
studi
also
exclud
episod
care
sought
medic
facil
howev
believ
cohort
captur
popul
fairli
comprehens
due
multipl
factor
first
parent
like
return
hospit
due
complex
care
requir
preterm
infant
especi
year
postdischarg
ill
requir
hospit
admiss
second
healthcar
relationship
result
long
stay
nicu
subsequ
longterm
followup
postdischarg
avail
outpati
servic
audit
data
infant
g
show
return
routin
neurodevelopment
assess
clinic
year
age
final
singapor
small
size
approxim
excel
transport
link
across
island
make
conveni
return
kkh
seek
medic
care
present
data
rvi
longterm
retrospect
cohort
preterm
infant
week
gestat
tropic
burden
rvi
preterm
infant
tropic
high
laboratoryconfirm
infect
year
age
predischarg
rsv
piv
main
respiratori
virus
detect
postdischarg
commun
rsv
key
caus
pathogen
incid
infect
remain
substanti
year
age
risk
factor
significantli
associ
rvi
preterm
infant
extrem
low
gestat
age
week
treatment
postnat
steroid
diagnosi
bpd
